Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment    

Global Drug Delivery Devices Market Research Report

PRODUCT TITLE PUBLISHED
Asian Drug Delivery Devices Market Asian Drug Delivery Devices Market
The Asian Drug Delivery Devices Market was valued at $28 billion in 2013 and expected to be $50 billion by 2018, growing at a CAGR of 12.6%. The report “Asian Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in this market and extensively covered in this report are 3M Company, Alkermes, Baxter International, Inc., Becton, Dickinson & Co., The Dow Chemical Company, Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC,.
Upcoming
North American Transdermal Drug Delivery Systems Market North American Transdermal Drug Delivery Systems Market
The North American Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $7.6 billion in 2013 and expected to be $12.7 billion by 2018, growing at a CAGR of 10.9%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Transdermal Drug Delivery Systems Market European Transdermal Drug Delivery Systems Market
The European Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $5.8 billion by 2018, growing at a CAGR of 9.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Transdermal Drug Delivery Systems Market Asian Transdermal Drug Delivery Systems Market
The Asian Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $1.5 billion in 2013 and expected to be $3.0 billion by 2018, growing at a CAGR of 14.8 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Pulmonary drug delivery devices Market North American Pulmonary drug delivery devices Market
The North American Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $13.8 billion in 2013 and expected to be $24 billion by 2018, growing at a CAGR of 11.8%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
European Pulmonary drug delivery devices Market European Pulmonary drug delivery devices Market
The European Pulmonary Drug Delivery devices devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $7.5 billion in 2013 and expected to be $12.4billion by 2018, growing at a CAGR of 10.6%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
Asian Pulmonary Drug Delivery devices Market Asian Pulmonary Drug Delivery devices Market
The Asian Pulmonary Drug Delivery devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $7.7 billion by 2018, growing at a CAGR of 16.2%. The Pulmonary Drug Delivery devices Market analyzes the market by segments such as nebulizers, dry powder inhalers (DPIs), and metered dose inhalers (MDIs).The prominent players in the Market are GlaxoSmithKline Pharmaceuticals Limited (GSK), Boehringer Ingelheim GmbH, and Astra Zeneca.
Upcoming
North American Active Transdermal Drug Delivery Devices Market North American Active Transdermal Drug Delivery Devices Market
The North American Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $712 million in 2013 and expected to be $1339 million by 2018, growing at a CAGR of 13.5 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Active Transdermal Drug Delivery Devices Market European Active Transdermal Drug Delivery Devices Market
The European Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $353 million in 2013 and expected to be $633 million by 2018, growing at a CAGR of 12.4 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Active Transdermal Drug Delivery Devices Market Asian Active Transdermal Drug Delivery Devices Market
The Asian Active Transdermal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $109 million in 2013 and expected to be $188 million by 2018, growing at a CAGR of 11.6 %. The Transdermal Drug Delivery Devices Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Passive Transdermal Drug Delivery Market North American Passive Transdermal Drug Delivery Market
The North American Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $6.85 billion in 2013 and expected to be $11.33 billion by 2018, growing at a CAGR of 10.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Passive Transdermal Drug Delivery Market European Passive Transdermal Drug Delivery Market
The European Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $3.27 billion in 2013 and expected to be $5.19 billion by 2018, growing at a CAGR of 9.6 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Passive Transdermal Drug Delivery Market Asian Passive Transdermal Drug Delivery Market
The Asian Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $1.40 billion in 2013 and expected to be $2.82 billion by 2018, growing at a CAGR of 15.0%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Implantable Drug Delivery Devices Market North American Implantable Drug Delivery Devices Market
The North American Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $4.0 billion in 2013 and expected to be $5.4 billion by 2018, growing at a CAGR of 6.1 %. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.
Upcoming
European Implantable Drug Delivery Devices Market European Implantable Drug Delivery Devices Market
The European Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $2.5 billion in 2013 and expected to be $3.2 billion by 2018, growing at a CAGR of 5.3 %. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.
Upcoming
Asian Implantable Drug Delivery Devices Market Asian Implantable Drug Delivery Devices Market
The Asian Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $1.6 billion in 2013 and expected to be $2.4 billion by 2018, growing at a CAGR of 8.8%. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.
Upcoming
North American Injectables Drug Delivery devices Market North American Injectables Drug Delivery devices Market
The North American Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $4.6 billion in 2013 and expected to be $7.2 billion by 2018, growing at a CAGR of 9.2%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Upcoming
European Injectables Drug Delivery devices Market European Injectables Drug Delivery devices Market
The European Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $3.9 billion in 2013 and expected to be $6.7 billion by 2018, growing at a CAGR of 11.1%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Upcoming
Asian Injectables Drug Delivery devices Market Asian Injectables Drug Delivery devices Market
The Asian Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $2.1 billion in 2013 and expected to be $4.1 billion by 2018, growing at a CAGR of 14.4%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Upcoming
Asia Conventional Injectable Drug delivery Devices Asia Conventional Injectable Drug delivery Devices
Conventional Injectable Drug delivery Devices-Asia market has been pegged at 0.0m in the year 2013 growing at annually and is projected to reach 0.0m by the end of the year 2018. It is segmented on basis of . What makes our report unique?...
Upcoming
62 reports | Show
Connect With Us
US/CAN : +1-888-502-0539